e-Drug3D 1291 |
CASPOFUNGIN
|
cas 162808-62-0 |
CLASS ANTIINFECTIVES |
ROUTE (list) INTRAVENOUS |
ATC code |
PK parameters VD 8.45 LITER (65 KILOGRAM) Solubility FREELY SOLUBLE IN WATER |
Target TARGET BETA-1,3-GLUCAN SYNTHASE |
DrugCentral Beta-1,3-glucan synthase catalytic subunit 1 UNIPROT O13428 GSC1 1,3-beta-glucan synthase catalytic subunit FksP UNIPROT Q4WLT4 |
Download SDF file | 1-[(4R,5S)-5-[(2-aminoethyl)amino] -N2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-L-ornithine]-5-[(3R) -3-hydroxy-L-ornithine] pneumocandin B0 Formula: Calculated chemical properties: MW 1093.32 NB_atoms 77 XLogP -3.31 PSA 360.057 NB_HD 18 NB_HA 25 fsp3 0.75 Lipinski(0=no;1=yes) 0 |
FDA NDA 021227 (pdf not found) INN (CASPOFUNGIN ACETATE) CANCIDAS (MERCK) APPROVAL= AP YEAR= 2001 DISCONTINUED NDA 206110 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2016 NDA 207092 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (GLAND) APPROVAL= AP YEAR= 2017 NDA 207650 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (PHARMOBEDIENT) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 200833 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (HENGRUI PHARMA) APPROVAL= AP YEAR= 2018 NDA 205923 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (XELLIA PHARMS APS) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 209489 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (CIPLA) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 211263 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (AREVA PHARMS) APPROVAL= AP YEAR= 2021 NDA 216506 (pdf not found) INN (CASPOFUNGIN ACETATE) CASPOFUNGIN ACETATE (HANGZHOU ZHONGMEI) APPROVAL= AP YEAR= 2025 |
Other links: |